Heteroaryl quinolines as inhibitors of leukotriene biosynthesis

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/12 (2006.01) A61K 31/395 (2006.01) A61K 31/70 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 491/048 (2006.01) C07D 493/08 (2006.01) C07D 495/04 (2006.01) C07H 15/04 (2006.01)

Patent

CA 2167317

Compounds having formula (I) are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti- anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular, nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic, plaques.

L'invention concerne des composés de la formule (I), inhibiteurs de la biosynthèse des leucotriènes. Ces composés sont utiles comme agents antiasthmatiques, antiallergiques, antiinflammatoires et cytoprotecteurs. Ils sont également utiles dans le traitement d'angines, de spasmes cérébraux, de la glomérulonéphrite, d'hépathites, d'endotoxémies, de l'uvéite et de rejets d'allogreffes, ainsi que dans la prévention de la formation de plaques athéroscléreuses.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heteroaryl quinolines as inhibitors of leukotriene biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroaryl quinolines as inhibitors of leukotriene biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaryl quinolines as inhibitors of leukotriene biosynthesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1905238

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.